Pharmaceutical company Organon (NYSE:OGN) reported Q4 CY2024 results , but sales were flat year on year at $1.59 billion. On ...

GE HealthCare Technologies delivered solid fourth-quarter earnings, but domestic and international revenue growth remained ...

West Pharmaceutical Services forecast full-year profit and revenue below Wall Street estimates on Thursday due to a strong dollar and as the medical equipment maker's clients reduce inventory levels, ...